BODYW: the cashflow

MyFinsight

For the quarter ending 2025-09-30, BODYW had $13,762K increase in cash & cash equivalents over the period. $13,069K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30
Net loss	-8,079
Depreciation and amortization expense	6,789
Amortization of content assets	6,945
Provision for inventory	1,256
Realized losses on hedging derivative financial instruments	0
Change in fair value of warrant liabilities	-107
Equity-based compensation	4,744
Amortization of debt issuance costs	1,280
Paid-in-kind interest expense	218
Loss on debt extinguishment	-2,166
Change in lease assets	1,161
Inventory	-3,899
Content assets	2,294
Prepaid expenses	-4,718
Other assets	-23,378
Accounts payable	-5,234
Accrued expenses	-1,844
Deferred revenue	-17,434
Other liabilities	-4,795
Net cash provided by operating activities	16,767
Purchase of property and equipment	3,698
Net cash (used in) provided by investing activities	-3,698
Proceeds from exercise of stock options	67
Debt borrowings	25,000
Debt repayments	22,582
Proceeds from issuance of common shares in the employee stock purchase plan	78
Tax withholding payments for vesting of restricted stock	271
Payment of debt issuance costs	1,781
Net cash provided by (used in) financing activities	511
Effect of exchange rates on cash, cash equivalents, and restricted cash	182
Net increase (decrease) in cash, cash equivalents, and restricted cash	13,762
Cash and cash equivalents at beginning of period	20,187
Cash and cash equivalents at end of period	33,949

Unit: Thousand (K) dollars